Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values

被引:51
|
作者
Zhao, Ying [1 ]
Zhang, Jie [1 ]
Zhang, Juanwen [1 ]
Wu, Jianping [1 ]
机构
[1] Zhejiang Univ, Dept Lab Med, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
来源
PLOS ONE | 2011年 / 6卷 / 01期
关键词
FASTING PLASMA-GLUCOSE; COAGULATION ACTIVATION; CARDIOVASCULAR-DISEASE; HYPERGLYCEMIA; RISK; THROMBOEMBOLISM; COMPLICATIONS; MANAGEMENT; DIAGNOSIS;
D O I
10.1371/journal.pone.0016470
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: This study was designed to examine the relationship between shortened activated partial thromboplastin time (APTT) and increased fibrinogen values with diabetes mellitus. Methods: APTT, prothrombin time (PT), fibrinogen, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) levels were measured in 1,300 patients. Patients were divided into three groups according to their HbA1c and FPG levels. Results: When participants were grouped according to their HbA1c levels, we found significantly shorter APTT values (26.9+/-65.6 s) and increased fibrinogen levels (3.1, 1.9-6.3 g/L) in the diabetes group when compared with the other two groups. When participants were grouped according to their FPG levels, we found significantly shorter APTT values (26.9+/-66.2 s) and increased fibrinogen levels (3.1, 1.8-6.2 g/L) in the diabetes group when compared with the euglycemic group. Conclusions: Shorter APTT and increased fibrinogen levels might be useful hemostatic markers in patients with diabetes and in patients at high risk for diabetes.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT)
    Zhang, Lin
    Ye, Juan
    Luo, Qiuyun
    Kuang, Miaohuan
    Mao, Minjie
    Dai, Shuqin
    Wang, Xueping
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5373 - 5384
  • [42] Variation of activated partial thromboplastin time according to age and sex in a large population study: analytical and clinical implications
    Lippi, Giuseppe
    Meschi, Tiziana
    Borghi, Loris
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (02) : 177 - 178
  • [43] Monitoring of Unfractionated Heparin Using Activated Partial Thromboplastin Time: An Assessment of the Current Nomogram and Analysis According to Age
    Kim, Je Sang
    Lee, Hyun Jong
    Sung, Ji Dong
    Kim, Hee-Jin
    Lee, Soo-Youn
    Kim, June Soo
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 723 - 728
  • [44] Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar, Vani
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (04) : 408 - 411
  • [45] Unusual Initial Manifestation of Acquired Hemophilia A: A Normal Activated Partial Thromboplastin Time, Intramuscular Hematoma and Cerebral Hemorrhage
    Tsuyama, Nobuaki
    Ichiba, Toshihisa
    Naito, Hiroshi
    INTERNAL MEDICINE, 2016, 55 (22) : 3347 - 3349
  • [46] Effect of Oral Administration of Ibuprofen on Prothrombin Time, Activated Partial Thromboplastin and Platelet Count in Wistar Albino Rats
    Esima, Jonathan
    Zorte, Abraham
    Onwuli, O. Donatus
    Waribo, Helen Anthony
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (06) : 45 - 50
  • [47] Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes
    Tessari, P.
    Kiwanuka, E.
    Barazzoni, R.
    Vettore, M.
    Zanetti, M.
    DIABETOLOGIA, 2006, 49 (08) : 1955 - 1961
  • [48] Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT)
    Guy, Susan
    Kitchen, Steve
    Makris, Michael
    Maclean, Rhona M.
    Saccullo, Giorgia
    Vanveen, Joost J.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [49] A gene-centric analysis of activated partial thromboplastin time and activated protein C resistance using the HumanCVD focused genotyping array
    Gaunt, Tom R.
    Lowe, Gordon D. O.
    Lawlor, Debbie A.
    Casas, Juan-Pablo
    Day, Ian N. M.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2013, 21 (07) : 779 - 783
  • [50] CXC chemokine ligand 16 is increased in gestational diabetes mellitus and preeclampsia and associated with lipoproteins in gestational diabetes mellitus at 5years follow-up
    Lekva, Tove
    Michelsen, Annika E.
    Aukrust, Pal
    Roland, Marie Cecilie Paasche
    Henriksen, Tore
    Bollerslev, Jens
    Ueland, Thor
    DIABETES & VASCULAR DISEASE RESEARCH, 2017, 14 (06) : 525 - 533